Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,896,505 Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
The present invention provides chimeric and humanized versions of anti-CD19 mouse monoclonal antibodies. The invention further relates to pharmaceutical...
US-9,896,504 Human anti-alpha-synuclein antibodies
Provided are human alpha-synuclein-specific autoantibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays,...
US-9,896,503 Antigen associated with the neovasculature of tumour metastases
The invention relates to a binding member that binds the Extra Domain-A (ED-A) isoform of fibronectin for the treatment of tumour metastases.
US-9,896,502 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster...
US-9,896,501 Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs
The present invention provides, among other aspects, methods for the manufacture of plasma-derived immunoglobulin G compositions highly enriched for anti-brain...
US-9,896,500 Antibody capable of binding to influenza virus
The present invention provides a novel antibody capable of binding influenza virus. The antibody directed to the present invention consists of an amino acid...
US-9,896,499 Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth...
US-9,896,498 Tumor vascular disrupting agent polypeptide, gene, expression vector, and use thereof
The present invention relates to a tumor vascular disrupting agent polypeptide, gene, expression vector, and use thereof. The tumor vascular disrupting agent...
US-9,896,497 Toll-like receptor 2 binding epitope and binding member thereto
The present invention relates to the identification of a TLR2 binding epitope wherein binding of a binding member to the epitope serves to inhibit TLR2...
US-9,896,496 Derivative of an insulin analogue
The present invention provides a novel derivative of an analogue of human insulin, useful for the treatment of diabetes.
US-9,896,495 Acylated glucagon analogues
The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular,...
US-9,896,494 Long-acting polypeptides and methods of producing same
A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a...
US-9,896,493 Nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression
A nucleic acid or transgene comprising a modified VEGF 3'-untranslated region (3'-UTR) polynucleotide sequence and a polynucleotide sequence encoding a Vascular...
US-9,896,492 HJURP peptides and vaccines including the same
Isolated peptides derived from SEQ ID NO: 50 and fragments thereof that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable...
US-9,896,491 Composition for treatment of multiple sclerosis
Novel oligopeptides, combinations thereof and fusion proteins composed of the above-mentioned oligopeptides are disclosed. Oligopeptides are homologous in amino...
US-9,896,490 Semaphorin 3C variants, compositions comprising said variants and methods of use thereof
The present invention relates, according to some embodiments, to variants of Semaphorin 3C (Sema3C) having amino acid modifications at furin-like pro-protein...
US-9,896,489 Family of synthetic polynucleotide-binding peptides and uses thereof
The present invention provides novel synthetic peptides (including the TZIP peptide) as oncogenic and genetic modulators, including genetics of viruses, as well...
US-9,896,488 Protamine in treatment of neuronal injuries
The present invention relates to treatment of neuronal injury. The present invention discloses a novel use of an agent and a novel method for promoting neurite...
US-9,896,487 Amyloidosis-inhibiting polypeptides and their use
Isolated polypeptides that possess an a-sheet structure are disclosed that can be used to treat or diagnose amyloid diseases.
US-9,896,486 Mutated immunoglobulin-binding polypeptides
A polypeptide with improved alkaline stability, which polypeptide comprises a mutant of a B or C domain of Staphylococcus Protein A, as specified by SEQ ID NO 1...
US-9,896,485 Nanopore sensors and uses thereof
Aspects of the invention relate to nanopores useful as sensors for detecting intermolecular interactions.
US-9,896,484 Influenza virus recombinant proteins
The present invention includes influenza Hemagglutinin protein fragments that fold properly when expressed in bacteria.
US-9,896,483 Stabilized hepatitis B core polypeptides
Genetically modified HBc polypeptides are provided.
US-9,896,482 Beta hairpin peptides having antiviral properties against Dengue virus
The present invention discloses structurally constrained synthetic peptides that have been optimized for the formation of a beta hairpin structure. Said...
US-9,896,481 Modified mini-hepcidin peptides and methods of using thereof
Disclosed herein are peptides which exhibit hepcidin activity and methods of making and using thereof.
US-9,896,480 Integrin receptor antagonists and their methods of use
Compounds comprising R-G-Cysteic Acid (i.e., R-G-NH--CH(CH.sub.2--SO.sub.3H)COOH or Arg-Gly-NH--CH(CH.sub.2--SO.sub.3H)COOH) and derivatives thereof, ...
US-9,896,479 Functionalized naphthalene fluorophores
Methods for the synthesis and use of functionalized, substituted naphthalenes are described. The functionalized, substituted naphthalenes display useful...
US-9,896,478 Antibody purification by cation exchange chromatography
A method for purifying an antibody by cation exchange chromatography is described in which a high pH wash step is used to remove of contaminants prior to...
US-9,896,477 Limonin extraction method
A limonin extraction method, comprising the following steps: step one, raw material extracting or juicing: directly soaking raw material in water or using a...
US-9,896,476 Glycyrrhetic acid derivatives
The glycyrrhetic acid derivatives can include: ##STR00001## The glycyrrhetic acid derivatives can be used to treat inflammation and/or ulcers.
US-9,896,475 Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl) imidazole and pharmaceutical compositions containing the same are provided. The present...
US-9,896,474 (3A,9B,10A,13A,14B,17A,20S,22E)-ergosta-5,7,22-trien-3-ol and methods of preparing and using the same
(3.alpha.,9.beta.,10.alpha.,13.alpha.,14.beta.,17.alpha.,20S,22E)-Ergosta- -5,7,22-trien-3-ol. A method for preparing the same by drying a fruiting body of...
US-9,896,473 Thiol compounds and the use thereof for the synthesis of modified oligonucleotides
The present invention relates to a thiol compound suitable for forming a chain of oligomers that can be grafted to an oligonucleotide. The invention also...
US-9,896,472 Protected monomer and method of final deprotection for RNA synthesis
A method of deprotecting a solid support bound polynucleotide includes the step of contacting the polynucleotide with a composition comprising a diamine under...
US-9,896,471 Salt of 1-(2-deoxy-2-fluoro-4-thio-.beta.-D-arabinofuranosyl)cytosine
A superior antitumor agent is provided. A salt of 1-(2-deoxy-2-fluoro-4-thio-.beta.-D-arabinofuranosyl)cytosine shows at least one or more of such...
US-9,896,470 Enhancing the stability and purity and increasing the bioavailability of human milk oligosaccharides or...
The present application discloses a method for enhancing the stability of a human milk oligosaccharide (HMO) or a HMO precursor or a HMO blend when stored for...
US-9,896,469 Method for fractionating lignin
The present invention relates to a method for fractionating lignin, wherein the method comprises the following steps: (i) dissolving lignin into a mixture...
US-9,896,468 Metal alkoxide compound, thin-film-forming material, method for producing thin film, and alcohol compound
Disclosed is a metal alkoxide compound having physical properties suitable for a material for forming thin films by CVD, and particularly, a metal alkoxide...
US-9,896,467 Organic compound with tetrahedral-like geometry
An organic compound with a tetrahedral-like geometry is disclosed. The organic compound has a structure represented by formula (I): ##STR00001## wherein A1...
US-9,896,466 Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level
The subject of the invention are new mitochondrially targeted E/Z isomers of aliphatic triphenylphosphonium derivatives of tamoxifen where the aliphatic chain...
US-9,896,464 Pantothenate derivatives for the treatment of neurological disorders
Compounds having the following formula (E): Formula E or a pharmaceutically acceptable salt thereof, wherein R, R', R'', X and n are as defined herein are...
US-9,896,463 Preparation of purified phosphorodiamidite
The instant invention relates to a method of phosphorodiamidite production that comprises: (E1) preparing a purified solution of a dialkylamine in a polar...
US-9,896,462 Metal halide perovskites, methods, and devices
Provided herein are metal halide perovskites that may have a 0D crystal structure, and may be lead free. Also provided are methods for making the metal halide...
US-9,896,461 Polysilylated organosilane compounds
The invention concerns a mono- or polyfunctional polysilylated organosilane compound, and the method for preparing same.
US-9,896,460 Molecular switches based on cis/trans isomerization of BF2-coordinated azo compounds
Provided herein are photochromic organic compounds of Formula I or Formula II, which are useful as molecular switches capable of being triggered via a cis/trans...
US-9,896,459 Azaindoles as respiratory syncytial virus antiviral agents
Azaindoles having inhibitory activity on RSV replication and having the formula I ##STR00001## compositions containing these compounds as active ingredient...
US-9,896,458 Compounds, compositions and methods
The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.
US-9,896,457 Microbial product having antifungal activity
Provided are a compound having a novel mother nucleus, which can be a promising drug discovery seed compound, use thereof as an antifungal agent, and a...
US-9,896,456 Pharmaceutical compound having inhibitory activity against cholesterol acyltransferase isozyme 2 (ACAT2)
This invention provides a novel non-natural pharmaceutical compound having a different mechanism than statin drugs and having a selective inhibitory activity...
US-9,896,455 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
The present invention provides tricyclic compounds having cytostatic and cytotoxic activity in a single molecule having receptor tyrosine kinase(s),...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.